CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review

The chimeric antigen receptor (CAR) plays a dynamic role in targeting tumour-associated antigens in cancer cells. This novel therapeutic discovery combines fragments of monoclonal antibodies with the signalling and co-stimulatory domains that have been modified to its current fourth generation. CAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Ler Yie, Dass, Sylvia Annabel, Tye, Gee Jun, Imran, Siti A. M., Wan Kamarul Zaman, Wan Safwani, Nordin, Fazlina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024487/
https://www.ncbi.nlm.nih.gov/pubmed/35453554
http://dx.doi.org/10.3390/biomedicines10040804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024487/
https://www.ncbi.nlm.nih.gov/pubmed/35453554
http://dx.doi.org/10.3390/biomedicines10040804

Ejemplares similares